Breast cancer cells are subtyped as ER+/PR + HER2 - (luminal A), ER+ and/or PR + HER2+ (luminal B), ER- and PR-/HER2+ (HER2-enriched), and ER—and/or PR—HER2- (triple-negative). This evidence concerns the gene ESR1 and breast carcinoma.